Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideDGXQuest Diagnostics
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | DGX | TMO |
|---|
| Close | 247.08 | 648.43 |
| Market Cap | $27.3B | $240B |
| 1M | +4.91% | +10.75% |
| P/E (TTM) | 25.7 | 34.4 |
| Forward P/E | 20.1 | 21.8 |
| P/E 5-Yr Percentile | 97 | 65 |
| P/S | 2.4 | 5.2 |
| P/B | 3.6 | 4.6 |
| Dividend Yield | 2.10% | 0.29% |
| Latest Quarter Revenue | $3.0B | $12.0B |
| Revenue YoY | +10.2% | +10.5% |
| Gross Margin | 33.7% | — |
| Latest Quarter EPS | 2.84 | 4.68 |
| Avg Post-Earnings Move | ±1.7% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.98% | 2.36% |
| 90-Day Net Insider Buying | −$8.3M | −$38.9M |
DGX · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
